Brankica Brana Culibrk

Dynamic and detail-oriented Research Assistant with a strong commitment to contributing to a full-time role that presents professional challenges. Demonstrates exceptional interpersonal skills, effective time management, and problem-solving expertise. Proven experience in clerical and laboratory environments enhances the ability to advance research objectives, with a strong emphasis on data review, reporting, and specimen handling. A collaborative team player dedicated to driving success in research initiatives, specializing in proteomics, cell biology, and flow cytometry to achieve impactful results. Committed to continuous learning and growth within the scientific community, ensuring alignment with the latest advancements and methodologies.

• Application of the ADVIA cerebrospinal fluid assay to count residual red blood cells in blood components B Culibrk, E Stone, E Levin, S Weiss, K Serrano, DV Devine Vox Sanguinis 103 (3), 186-193, 2012
• Implementation of buffy coat platelet component production: comparison to platelet-rich plasma platelet production E Levin, B Culibrk, MIC Gyöngyössy-Issa, S Weiss, K Scammell, ... Transfusion 48 (11), 2331-2337, 2008
• Platelet Storage Lesion: Analyses of Molecular Mechanisms by Targeting Protein Kinases: SP14 P Schubert, B Culibrk, D Devine Transfusion 50, 62A-63A, 2010
• Development of a quality monitoring program for platelet components: a report of the first four years' experience at Canadian Blood Services E Levin, C Jenkins, B Culibrk, MIC Gyöngyössy-Issa, K Serrano, ... Transfusion 52 (4), 810-818, 2012
• Riboflavin and ultraviolet light treatment potentiates vasodilator-stimulated phosphoprotein Ser-239 phosphorylation in platelet concentrates during storage P Schubert, B Culibrk, D Coupland, K Scammell, M Gyongyossy-Issa, ... Transfusion 52 (2), 397-408, 2012
• Protein translation occurs in platelet concentrates despite riboflavin/UV light pathogen inactivation treatment P Schubert, S Karwal, RP Goodrich, DV Devine PROTEOMICS–Clinical Applications 10 (8), 839-850, 2016
• Efficiency of riboflavin and ultraviolet light treatment against high levels of biofilm-derived Staphylococcus epidermidis in buffy coat platelet concentrates M Taha, B Culibrk, M Kalab, P Schubert, QL Yi, R Goodrich, ... Vox Sanguinis 112 (5), 408-416, 2017
• Altered timing of riboflavin and ultraviolet light pathogen inactivation improves platelet in vitro quality P Schubert, B Culibrk, S Karwal, K Serrano, E Levin, QL Yi, T Thiele, ... Transfusion 57 (8), 2026-2034, 2017
• Improved in vitro quality of stored red blood cells upon oxygen reduction prior to riboflavin/UV light treatment of whole blood P Schubert, B Culibrk, D Chen, K Serrano, E Levin, Z Chen, P Zoescher, ... Transfusion 59 (10), 3197-3204, 2019
• Releasates of riboflavin/UV-treated platelets: Microvesicles suppress cytokine-mediated endothelial cell migration/proliferation P Schubert, L Culibrk, B Culibrk, EM Conway, RP Goodrich, DV Devine Transfusion 61 (5), 1551-1561, 2021
• Minimal impact of anticoagulant on in vitro whole blood quality throughout a 35-day cold-storage regardless of leukoreduction timing P Schubert, B Culibrk, V Bhakta, T Closas, WP Sheffield, DV Devine, ... Transfusion 62, S98-S104, 202